Kisquali Femara Co-Pack (Letrozole and Ribociclib | Friends of Cancer Research

You are here

Kisquali Femara Co-Pack (Letrozole and Ribociclib

Sponsor: 
Novartis Pharmaceuticals Corporation
Indication: 
Treatment of pre/perimenopausal women with HR-positive, HER2- negative advanced or metastatic breast cancer
Category: 
Year: 
2018
Date: 
Jan 10th
FDA Status: 
FDA Approval
Approval Date: 
Feb 13th
Approval Year: 
2019